3 Stocks I Saw on T...
Health Care: Drugs
Flamel Technologies (FLML: NASDAQ)
$4.43 0.09 | 1.98%
06/04/12 - 12:14 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.34 |
| 52 Week High | 7.70 |
| 52 Week Low | 3.61 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 0.86 |
| Share Related Items | |
| Mkt Cap (Mil) | 108.33 |
| Shares Out (Mil) | 24.96 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.80 |
| Current Ratio | 2.00 |
| LT Debt/ Equity | 0.07 |
| Total Debt / Equity | 0.14 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 3.32 |
| Price/Book | 3.64 |
| Price/Cash Flow | -20.00 |
| Per Share Data | |
| Earnings | -0.36 |
| Sales | 1.31 |
| Book Value | 1.19 |
| Cash Flow | -0.22 |
| Business Summary | |
|---|---|
| Flamel Technologies, S.A. is a biopharmaceutical company mainly engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications. | |
| General Information | |
| Parc Club du Moulin a Vent
33 Avenue du Docteur Georges Venissieux, 69693 |
|
| www.flamel.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 267 | |
| CEO: Mr. Michael S. Anderson | |
| Short Interest | |
| Current Month (Mil) | 0.13 |
| Previous Month (Mil) | 0.13 |
| Short Interest Ratio (Days) | 5.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -12.60 |
| Return on Investments | -27.00 |
| Profitability | |
| Gross Margin | 91.00 |
| EBIT Margin | -26.10 |
| Profit Margin | -26.90 |
Portfolios with FLML
- Portfolio NameUser Type
- Contributor10 Top-Rated Buys Under $10
- Contributor10 Stocks Under $10 With Up...
- Usergreentree
- UserSalvelinus Fontinalis
- UserBVF Inc.
- UserBoondoggler22 Portfolio 1
- UserFATZ 1
- Userndecas Portfolio 1
- UserRooster Fund
- UserLGS-1 Portfolio 1
Latest FLML Headlines from TheStreet
- Flamel Technologies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.07.12 | 11:05 am
- Flamel Technologies' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.15.12 | 01:03 pm
- Flamel Technologies's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 11:11 am
- Flamel Technologies CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.26.11 | 01:07 pm
- Flamel Technologies CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.09.11 | 10:05 am
- Flamel Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript 03.04.11 | 12:03 pm
- Flamel Technologies CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.05.10 | 11:11 pm
- Flamel Technologies SA Q2 2010 Earnings Call Transcript 07.29.10 | 02:07 pm
- Thursday's Health Winners & Losers 12.20.07 | 02:12 pm
- Wednesday's Health Winners & Losers 12.05.07 | 04:12 am
Press Releases for FLML
- Flamel Technologies Announces First Quarter 2012 Results - Business Wire 05.07.12 | 07:05 am
- Flamel Technologies Announces Fourth Quarter And Year-End 2011 Results - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Acquisition Of Éclat Pharmaceuticals - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Profitable Third Quarter Results - Business Wire 11.02.11 | 04:11 pm
- Flamel Technologies Announces Multi-Year Supply Agreement With GlaxoSmithKline For Coreg CR™ Microparticles - Business Wire 10.18.11 | 08:10 am
- Eagle Pharmaceuticals And Flamel Technologies Announce Eagle To License Medusa Technology For Extended-Release Of Tigecycline - Business Wire 10.13.11 | 09:10 am
- Flamel Technologies And Digna Biotech Announce Multiple Product Development Agreement - Business Wire 06.27.11 | 08:06 am
- Flamel Technologies Announces Results Of Annual Meeting - Business Wire 06.24.11 | 08:06 am
- Flamel Technologies Announces Nomination Of Ambassador Craig Stapleton, Dr. Catherine Bréchignac And Mr. Guillaume Cerutti For Election To The Board Of Directors - Business Wire 05.31.11 | 08:05 am
- Flamel Technologies Announces Expanded Partnership Relations; First Quarter Results - Business Wire 05.09.11 | 06:05 am
Partner Headlines for FLML
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- Investors roll positions on options expiration day - Reuters 08.20.10 | 03:08 pm
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.04.10 | 09:08 am
